Craneware plc Blocklisting Application (9714G)
March 20 2020 - 5:00AM
UK Regulatory
TIDMCRW
RNS Number : 9714G
Craneware plc
20 March 2020
Craneware plc
("Craneware" or the "Company")
Blocklisting Application
Craneware plc (AIM: CRW.L), the market leader in Value Cycle
solutions for the US healthcare market, announces that a block
listing application has been made to the London Stock Exchange for
350,000 ordinary shares of one pence each ("Ordinary Shares") to be
admitted to trading on AIM (the "Admission"). The Ordinary Shares
that are being reserved under this block listing application will
be issued by the Company, as required, in order to satisfy the
exercise of share options and vested awards pursuant to the terms
of the following share plans:
Share plan Number of Ordinary
Shares
The Craneware plc Schedule 4 Company Share
Option Plan (2016) 50,000
-------------------
The Craneware plc Unapproved Company Share
Option Plan (2016) 200,000
-------------------
The Craneware plc Long Term Incentive Plan
(2016) 100,000
-------------------
Total 350,000
-------------------
It is expected that Admission of these Ordinary Shares will
become effective on 23 March 2020. When issued, the Ordinary Shares
will be credited as fully paid and will rank pari passu in all
respects with the existing Ordinary Shares.
For further information, please contact:
Craneware plc Peel Hunt Investec Bank Alma
(NOMAD & Joint (Joint Broker) (Financial PR)
Broker)
+44 (0)131 550 +44 (0)20 7418 +44 (0)20 7597 +44 (0)203 405
3100 8900 5970 0205
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan
CFO
Andrew Clark Henry Reast Helena Bogle
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle
solutions, collaborates with U.S. healthcare providers to plan,
execute and monitor value-based economic performance. Founded in
1999, Craneware is headquartered in Edinburgh, Scotland with
offices in Atlanta and Pittsburgh employing over 350 staff.
Craneware's value cycle management suite includes charge capture,
strategic pricing, patient engagement, claims analytics, revenue
recovery and retention, and cost and margin intelligence
solutions.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSPPUWAWUPUUMU
(END) Dow Jones Newswires
March 20, 2020 05:00 ET (09:00 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024